The FDA is not only approving a lot more drugs these days, it seems to have also developed a sense of dramatic timing. Late last Friday, the agency approved its sixth checkpoint inhibitor, a type of cancer drug that blocks a tumor’s ability to hide from the immune system. Less than 72 hours later, two […]
Original Article: FDA’s Latest Cancer Approval Underscores Immunotherapy Nobel Prize